Nuveen’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.75M Buy
120,717
+67,515
+127% +$784K ﹤0.01% 2325
2025
Q4
$511K Buy
53,202
+22,830
+75% +$219K ﹤0.01% 2860
2025
Q3
$285K Hold
30,372
﹤0.01% 3072
2025
Q2
$321K Sell
30,372
-10,943
-26% -$138K ﹤0.01% 3023
2025
Q1
$621K Hold
41,315
﹤0.01% 2830
2024
Q4
$680K Hold
41,315
﹤0.01% 2876
2024
Q3
$1.02M Sell
41,315
-58,761
-59% -$1.52M ﹤0.01% 2750
2024
Q2
$2.53M Sell
100,076
-96,100
-49% -$2.49M ﹤0.01% 2269
2024
Q1
$4.98M Sell
196,176
-69,300
-26% -$1.68M ﹤0.01% 1998
2023
Q4
$6.02M Buy
265,476
+128,369
+94% +$2.66M ﹤0.01% 1876
2023
Q3
$2.55M Buy
137,107
+22,455
+20% +$466K ﹤0.01% 2202
2023
Q2
$2.98M Sell
114,652
-6,560
-5% -$176K ﹤0.01% 2168
2023
Q1
$3.48M Buy
121,212
+51,420
+74% +$1.53M ﹤0.01% 2087
2022
Q4
$2.07M Buy
69,792
+15,079
+28% +$429K ﹤0.01% 2376
2022
Q3
$1.3M Sell
54,713
-852
-2% -$19.6K ﹤0.01% 2618
2022
Q2
$1.24M Sell
55,565
-3,449
-6% -$76.9K ﹤0.01% 2691
2022
Q1
$1.58M Buy
59,014
+528
+0.9% +$16.1K ﹤0.01% 2618
2021
Q4
$2.16M Sell
58,486
-3,785
-6% -$152K ﹤0.01% 2536
2021
Q3
$2.47M Sell
62,271
-29,680
-32% -$1.22M ﹤0.01% 2578
2021
Q2
$3.98M Buy
91,951
+27,254
+42% +$1.16M ﹤0.01% 2356
2021
Q1
$2.64M Sell
64,697
-915
-1% -$34.7K ﹤0.01% 2484
2020
Q4
$2.97M Sell
65,612
-1,864
-3% -$70.7K ﹤0.01% 2314
2020
Q3
$2.39M Buy
67,476
+4,761
+8% +$172K ﹤0.01% 2291
2020
Q2
$2.37M Buy
62,715
+9,267
+17% +$305K ﹤0.01% 2268
2020
Q1
$1.54M Sell
53,448
-97,303
-65% -$3.94M ﹤0.01% 2313
2019
Q4
$7.82M Sell
150,751
-60,919
-29% -$3.54M ﹤0.01% 1737
2019
Q3
$11.6M Buy
211,670
+155,339
+276% +$7.98M ﹤0.01% 1472
2019
Q2
$2.29M Buy
+56,331
New +$2.05M ﹤0.01% 2371

Other funds holding ANIK